Researchers Turn To Experimental Drug to Improve The Effectiveness of Chemotherapy Against Mesothelioma

Researchers are turning to an experimental, metal-based anti-cancer drug to increase the effectiveness of chemotherapy in mesothelioma patients. While chemotherapy is used in the treatment of nearly all pleural mesothelioma patients, the cancer eventually develops a resistance to the drugs rendering them ineffective. However, by first treating the patient with the ruthenium-containing drug RAPTA-T, the mesothelioma tumors may more readily absorb the chemotherapy and slow the growth. A team of researchers from the Centre Hospitalier Universitaire Vaudois, Switzerland, and the Swiss Federal Institute of Technology, determined that in order to be effective, chemotherapy drugs must first reach the tumor with […]

The post Researchers Turn To Experimental Drug to Improve The Effectiveness of Chemotherapy Against Mesothelioma appeared first on Mesothelioma Help Cancer Organization.

from Blog – Mesothelioma Help Cancer Organization https://ift.tt/2JYfLCv
via IFTTT